From Kauten Takes Helm of Lucigen as it Heads Down New Diagnostic Path:

Ralph Kauten

Ralph Kauten—

Ralph Kauten, a serial entrepreneur based in the Madison, WI, area, is the current CEO of Lucigen and former CEO of Quintessence Biosciences.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

Sponsored · Webinar
Nov. 12 – High-Throughput Assessment of Compound-Induced Cardiotoxicity Using Human iPSC-Derived Cardiomyocytes
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!